Pancreatic Cancer
Pancreatic cancer is a type of cancer that begins in the pancreas, often leading to symptoms like abdominal pain, weight loss, and jaundice. It is known for being aggressive and difficult to detect early.
We are studying a new imaging method for patients with newly diagnosed esophagogastric and pancreatic cancers. This trial aims to see if it detects cancer better than current imaging techniques.
Health conditions and diseases that the clinical trial is designed to study and treat.
Pancreatic cancer is a type of cancer that begins in the pancreas, often leading to symptoms like abdominal pain, weight loss, and jaundice. It is known for being aggressive and difficult to detect early.
Esophagogastric adenocarcinoma refers to cancers that occur in the esophagus and stomach, often presenting symptoms such as difficulty swallowing, persistent heartburn, and unexplained weight loss.
Gastric cancer, or stomach cancer, is a type of cancer that develops from the lining of the stomach, leading to symptoms like stomach pain, bloating, and changes in appetite.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.